New Prostate Cancer Test Improves Risk Assessment

Submitted by Elizabeth Fernandez on May 8, 2013 at 4:16 pm
Share to Facebook Share to Twitter Share via E-mail

Dr. Peter Carroll speaks at the AUAA new genomic test for prostate cancer can help predict whether men are more likely to harbor an aggressive form of the disease, according to a new UC San Francisco study.

The test, which improves risk assessment when patients are first diagnosed, can also aid in determining which men are suitable for active surveillance – a way of managing the disease without direct treatment.

For the full story from UCSF click here to read more



Dr. Peter Carroll interview on CBS May 8th 2013NBC Nightly News   |  May 08, 2013

New prostate cancer test may prevent overtreatment

By engaging in active surveillance, experts say, doctors can better understand whether or not it’s safe for men to go untreated for prostate cancer. There are several tests that already predict how dangerous a tumor is, but a new test from the company Genomic Health provides doctors with more information by analyzing multiple genes. NBC’s Richard Bazell reports.



Dr. Peter Carroll interview on CBS May 8th 2013CBS News  |  May 08, 2013

HealthWatch: Genetic Test Fives Clue To Dangers Of Prostate Cancer

UCSF doctor Peter Carroll headed up a study that took a look at how a new test – designed by Redwood City’s Genomic Health – analyzes certain genes from a tumor to determine its risk of rapid growth. Allen Martin reports.




Other news coverage:

The Associated Press
San Francisco Chronicle